why choose us

First received: February 20, 2025

Clinical Trial: A Pilot Study of Selenomethionine and Myo-inositol(SOLOWAYS_TM) in Patients with Autoimmune Thyroiditis Carrying the DIO2 Thr92Ala Polymorphism

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Autoimmune Thyroiditis

Study Type: INTERVENTIONAL


Official Title: A Pilot Study of Selenomethionine and Myo-inositol(SOLOWAYS_TM) in Patients with Autoimmune Thyroiditis Carrying the DIO2 Thr92Ala Polymorphism

Brief Summary: This pilot, genotype-stratified clinical trial aims to evaluate the safety and preliminary efficacy of combined selenomethionine and myo-inositol supplementation in patients with autoimmune thyroiditis (AIT), including Hashimoto's thyroiditis, who carry the Thr92Ala (rs225014) variant in the DIO2 gene.The study will compare changes in thyroid function tests, autoantibody titers, and clinical symptoms between two cohorts: (1) carriers (homozygous or heterozygous) of the Thr92Ala variant and (2) individuals…

Read more